Quadro Acquisition One Corp.: Nasdaq/NYSE listing notice — Quadro Acquisition One receives Nasdaq deficiency notice over committee composition after director resignations

Quadro Acquisition One Corp.

Notice received Dec 27, 2023 from Nasdaq due to resignations of Clifford Tompsett and Leonid Zilber from board effective Nov 21, 2023.
Audit Committee and Compensation Committee each now have only one member, violating Nasdaq Listing Rule 5605 (need three and two).
Company has until Feb 12, 2024 to submit a compliance plan; Nasdaq may grant up to 180-day extension.
Company intends to cure by appointing additional independent directors; failing plan acceptance, hearing request stays delisting.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Quadro Acquisition One Corp. received a nasdaq deficiency notice notice regarding audit committee (rules 5605).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: audit committee
Rules: 5605

Exact text from the filing

December 27, 2023, Quadro Acquisition One Corp., a Cayman Islands exempted company (the “Company”), received a deficiency notice (“Notice”) from the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, as a result of the resignations of Clifford Tompsett and Leonid Zilber from the board of directors of the Company (the “Board”) and the audit committee and compensation committee of the Board (“Audit Committee” and “Compensation Committee,” respectively) effective November 21, 2023, the Company is no longer in compliance with the continued listing requirements set forth in Nasdaq Listing R

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001213900-24-000815

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.